Back to Journals » Therapeutics and Clinical Risk Management » Volume 5
Review
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,275 | Dovepress* | 14,275+ | 2,326 | 16,601 | |
Totals | 14,275 | 2,326 | 16,601 | ||
*Since 25 September 2009 +Since July 2016 |
View citations on Google Scholar